Liebert Debra K.'s Form 4 filing
Milestone Pharmaceuticals Inc. (MIST) · filed Oct 21, 2022
- Accession no.
- 0001209191-22-054326
- Filed
- Oct 21, 2022
- Trade date
- Oct 20-21, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $73.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Liebert Debra K.CIK 0001772891 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2022 | Common Shares | PPurchaseAcquired | +10,000 | $5.29 | +$52,900 | 10,000 | Indirect | |
| Oct 21, 2022 | Common Shares | PPurchaseAcquired | +4,000 | $5.26 | +$21,040 | 4,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.